SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328700. A total of 52 filers reported holding SUNESIS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.78 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $3,375,000 | +22.9% | 8,134,926 | 0.0% | 3.69% | +39.3% |
| Q4 2019 | $2,747,000 | -28.6% | 8,134,926 | +52.2% | 2.65% | -38.9% |
| Q3 2019 | $3,848,000 | +100.1% | 5,345,826 | +102.0% | 4.34% | +98.7% |
| Q2 2019 | $1,923,000 | +470.6% | 2,645,826 | +854.3% | 2.18% | +597.8% |
| Q1 2019 | $337,000 | +51.8% | 277,245 | +149.3% | 0.31% | +52.7% |
| Q3 2018 | $222,000 | +115.5% | 111,217 | +128.3% | 0.20% | +469.4% |
| Q2 2018 | $103,000 | – | 48,707 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|